IP Library Assignment 028774/0361
Patent Assignment
Reel/Frame 028774/0361

Merger

Recorded: 2012-08-13 Pages: 9
Assignor
CELL THERAPEUTICS EUROPE, S.R.L.
Executed: 2007-11-08
Assignee
CELL THERAPEUTICS, INC.
501 ELLIOTT AVENUE WEST, #400, SEATTLE, WASHINGTON, 98119
Covered Property (1)
Injectable Pharmaceutical Compositions of an Anthracenedione Derivative with Anti-Tumoral Activity
Patent: 9,211,262 →
Application: 12/964,861 →
Publication: US 2011/0144147
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 14, 2011
From: BERNAREGGI, ALBERTO; LIVI, VALERIA
To: CELL THERAPEUTICS EUROPE S.R.L.
Reel/Frame 025961/0263 →
Change of Name Nov 9, 2015
From: CELL THERAPEUTICS, INC.
To: CTI BIOPHARMA CORP.
Reel/Frame 037076/0727 →
Assignment of Assignor's Interest Apr 9, 2020
From: CTI BIOPHARMA CORP.; CTI LIFE SCIENCES
To: LES LABORATOIRES SERVIER
Reel/Frame 052353/0084 →